Literature DB >> 23665549

T helper-17 activation dominates the immunologic milieu of both amyotrophic lateral sclerosis and progressive multiple sclerosis.

Marina Saresella1, Federica Piancone, Paola Tortorella, Ivana Marventano, Andrea Gatti, Domenico Caputo, Christian Lunetta, Massimo Corbo, Marco Rovaris, Mario Clerici.   

Abstract

MS (multiple sclerosis) and ALS (amyotrophic lateral sclerosis) differ in important respects, but common pathogenic features seem to be shared in these two diseases. To shed light on such features, immunophenotypic and functional analysis were performed in peripheral monocytes and T lymphocytes of ALS and primary progressive (PP) MS patients and healthy controls (HC). Results showed that TH1-, TH17-, and IL-6-driven inflammation characterize both diseases; this is unsuccessfully hampered by TH2 activation and, possibly, BDNF secretion. Results herein clarify the pathogenic similarities between ALS and PP-MS and could be helpful for the design of novel diagnostic and therapeutic approaches to ALS.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23665549     DOI: 10.1016/j.clim.2013.04.010

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  29 in total

1.  Anti-inflammatory therapies of amyotrophic lateral sclerosis guided by immune pathways.

Authors:  Larry Lam; Ramesh C Halder; Dennis J Montoya; Liudmilla Rubbi; Arturo Rinaldi; Bien Sagong; Sarah Weitzman; Rachel Rubattino; Ram Raj Singh; Matteo Pellegrini; Milan Fiala
Journal:  Am J Neurodegener Dis       Date:  2015-12-28

Review 2.  Use of biomarkers in ALS drug development and clinical trials.

Authors:  Nadine Bakkar; Ashley Boehringer; Robert Bowser
Journal:  Brain Res       Date:  2014-10-24       Impact factor: 3.252

Review 3.  Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis.

Authors:  Kristopher G Hooten; David R Beers; Weihua Zhao; Stanley H Appel
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

4.  Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.

Authors:  Amanda K Huber; Lu Wang; Peisong Han; Xu Zhang; Sven Ekholm; Ashok Srinivasan; David N Irani; Benjamin M Segal
Journal:  Neurology       Date:  2014-09-24       Impact factor: 9.910

5.  CD4 Deficiency Causes Poliomyelitis and Axonal Blebbing in Murine Coronavirus-Induced Neuroinflammation.

Authors:  Debanjana Chakravarty; Fareeha Saadi; Soumya Kundu; Abhishek Bose; Reas Khan; Kimberly Dine; Lawrence C Kenyon; Kenneth S Shindler; Jayasri Das Sarma
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

6.  Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis: A Study of Humans and a Transgenic Mouse Model.

Authors:  Rebecca K Sheean; Fiona C McKay; Erika Cretney; Christopher R Bye; Nirma D Perera; Doris Tomas; Richard A Weston; Karlene J Scheller; Elvan Djouma; Parvathi Menon; Stephen D Schibeci; Najwa Marmash; Justin J Yerbury; Stephen L Nutt; David R Booth; Graeme J Stewart; Mathew C Kiernan; Steve Vucic; Bradley J Turner
Journal:  JAMA Neurol       Date:  2018-06-01       Impact factor: 18.302

Review 7.  Glial biomarkers in human central nervous system disease.

Authors:  Gwenn A Garden; Brian M Campbell
Journal:  Glia       Date:  2016-05-26       Impact factor: 7.452

8.  No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.

Authors:  An Goris; Jessica van Setten; Frank Diekstra; Stephan Ripke; Nikolaos A Patsopoulos; Stephen J Sawcer; Michael van Es; Peter M Andersen; Judith Melki; Vincent Meininger; Orla Hardiman; John E Landers; Robert H Brown; Aleksey Shatunov; Nigel Leigh; Ammar Al-Chalabi; Christopher E Shaw; Bryan J Traynor; Adriano Chiò; Gabriella Restagno; Gabriele Mora; Roel A Ophoff; Jorge R Oksenberg; Philip Van Damme; Alastair Compston; Wim Robberecht; Bénédicte Dubois; Leonard H van den Berg; Philip L De Jager; Jan H Veldink; Paul I W de Bakker
Journal:  Hum Mol Genet       Date:  2013-11-13       Impact factor: 6.150

Review 9.  Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact.

Authors:  Fabiola De Marchi; Ivana Munitic; Amedeo Amedei; James D Berry; Eva L Feldman; Eleonora Aronica; Giovanni Nardo; Donatienne Van Weehaeghe; Elena Niccolai; Nikolina Prtenjaca; Stacey A Sakowski; Caterina Bendotti; Letizia Mazzini
Journal:  Neurosci Biobehav Rev       Date:  2021-06-19       Impact factor: 9.052

10.  Determinants of disability in multiple sclerosis: an immunological and MRI study.

Authors:  Paola Tortorella; Maria Marcella Laganà; Marina Saresella; Eleonora Tavazzi; Maria Giulia Preti; Cristian Ricci; Francesca Baglio; Ivana Marventano; Federica Piancone; Giuseppe Baselli; Pietro Cecconi; Domenico Caputo; Mario Clerici; Marco Rovaris
Journal:  Biomed Res Int       Date:  2014-04-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.